Pharmacokinetics-based comprehensive early druggability evaluation method and application thereof
A technology of pharmacokinetics and evaluation methods, applied in the field of all-round early drugability evaluation based on pharmacokinetics, to achieve the effect of saving experimental animals, shortening development cycle and cost, and simple calculation
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Examples
Embodiment 1
[0022] A comprehensive early druggability evaluation method based on pharmacokinetics, comprising the following steps:
[0023] (1): Calculate the molecular descriptor of the drug to be evaluated;
[0024] (2): Input the molecular descriptor of the drug to be evaluated into the drug pharmacokinetic model trained by the known drug. The pharmacokinetic model of the drug is input as the molecular descriptor of the known drug, and the output is the pharmacokinetic model. The kinetic parameter data is obtained by training the neural network. The data include: drug dissociation degree, lipid-water partition coefficient under neutral conditions, solubility in water, elimination rate constant, free human plasma protein fraction, human whole blood plasma drug concentration ratio, Bioavailability, elimination half-life, mean residence time, apparent volume of distribution, and area under the first moment plasma concentration-time curve.
[0025] (3): Calculate the druggability score of...
Embodiment 2
[0035] A comprehensive early druggability evaluation method based on pharmacokinetics, comprising the following steps:
[0036] (1): Calculate the molecular descriptor of the drug to be evaluated;
[0037] (2): Input the molecular descriptor of the drug to be evaluated into the drug pharmacokinetic model trained by the known drug. The pharmacokinetic model of the drug is input as the molecular descriptor of the known drug, and the output is the pharmacokinetic model. The kinetic parameter data is obtained by training the neural network. The data include: drug dissociation degree, lipid-water partition coefficient under neutral conditions, solubility in water, elimination rate constant, free human plasma protein fraction, human whole blood plasma drug concentration ratio, Bioavailability, elimination half-life, mean residence time, apparent volume of distribution, and area under the first moment plasma concentration-time curve.
[0038] (3): Calculate the druggability score of...
PUM
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com